| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.23B | 1.20B | 1.15B | 1.09B | 1.12B |
| Gross Profit | 1.12B | 940.31M | 903.38M | 949.75M | 748.55M |
| EBITDA | 908.79M | 929.22M | 903.38M | 949.92M | 746.23M |
| Net Income | 674.24M | 688.07M | 665.51M | 704.16M | 546.68M |
Balance Sheet | |||||
| Total Assets | 6.89B | 6.55B | 6.22B | 5.74B | 5.91B |
| Cash, Cash Equivalents and Short-Term Investments | 582.49M | 599.43M | 615.68M | 513.77M | 425.83M |
| Total Debt | 744.48M | 760.32M | 768.68M | 771.26M | 775.82M |
| Total Liabilities | 1.54B | 1.55B | 1.59B | 1.63B | 1.81B |
| Stockholders Equity | 5.36B | 5.00B | 4.63B | 4.10B | 4.11B |
Cash Flow | |||||
| Free Cash Flow | 724.52M | 686.26M | 632.04M | 567.13M | -113.53M |
| Operating Cash Flow | 724.52M | 686.26M | 632.04M | 560.51M | 572.12M |
| Investing Cash Flow | -226.38M | -320.51M | -229.40M | -220.25M | -398.78M |
| Financing Cash Flow | -515.08M | -382.00M | -300.73M | -252.31M | -200.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $5.93B | 8.72 | 12.75% | 2.02% | 2.40% | 1.18% | |
82 Outperform | $2.97B | 8.30 | 16.17% | ― | 8.86% | 9.51% | |
76 Outperform | $5.69B | 9.33 | 12.35% | 1.88% | 2.78% | -0.50% | |
70 Outperform | $4.69B | 8.52 | 12.72% | 2.78% | -3.68% | 3.65% | |
68 Neutral | $5.78B | 8.93 | 14.31% | 1.89% | 2.20% | 9.90% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $7.09B | 10.21 | 11.95% | 3.58% | 25.99% | 426.44% |
On February 3, 2026, Enact Holdings reported fourth-quarter and full-year 2025 results showing continued profitability and capital strength, with Q4 GAAP net income of $177 million, or $1.22 per diluted share, and adjusted operating income of $179 million, or $1.23 per diluted share. For 2025, the company generated $674 million in net income, maintained a solid adjusted operating return on equity of 13.3%, and grew primary insurance in-force to $273 billion, up 2% year over year. Losses incurred fell to $18 million in the fourth quarter, driving a loss ratio of 7%, helped by a $60 million net reserve release tied to favorable cure performance and lower expected claim rates, while elevated persistency and stable net premiums earned supported earnings despite a challenging housing backdrop. Enact also underscored its robust capital position, with PMIERs sufficiency of 162% (about $1.9 billion) and book value per share of $37.66, and returned $503 million to shareholders in 2025 through dividends and $382 million of share repurchases. In a further demonstration of shareholder-return focus, the board on February 3, 2026 authorized a new share repurchase program of up to $500 million of common stock and the company entered into a stock buyback agreement with its majority owner Genworth Financial, moves that reinforce capital management discipline and signal confidence in the company’s long-term earnings power.
The most recent analyst rating on (ACT) stock is a Hold with a $40.00 price target. To see the full list of analyst forecasts on Enact Holdings stock, see the ACT Stock Forecast page.